「code」の検索結果
18件：6～10件目を表示
-
tarted Phase III clinical trials in Japan for an in-house developed compound having the development code SJP-0008. Central Retinal Artery Occlusion (CRAO), the therapeutic target of SJP-0008, occurs w...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509_0.pdf -
n; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1 antagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf -
nnounces that the orphan drug designation to the in-house developed compound having the development code SJP-0008 was granted by the Ministry of Health, Labor and Welfare (HMLW) on June 19, 2024, as a...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708_0.pdf -
nnounces that the orphan drug designation to the in-house developed compound having the development code SJP-0008 was granted by the Ministry of Health, Labor and Welfare (HMLW) on June 19, 2024, as a...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708.pdf -
tarted Phase III clinical trials in Japan for an in-house developed compound having the development code SJP-0008. Central Retinal Artery Occlusion (CRAO), the therapeutic target of SJP-0008, occurs w...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509.pdf